QBFM
ANGO icon

QS Batterymarch Financial Management’s AngioDynamics ANGO Stock Holding History

QS Batterymarch Financial Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.41M Sell
175,341
-19,410
-10% -$277K 0.06% 378
2014
Q2 		$3.18M Buy
194,751
+53,090
+37% +$769K 0.08% 364
2014
Q1 		$2.23M Buy
141,661
+122,087
+624% +$1.99M 0.05% 477
2013
Q4 		$336K Buy
+19,574
New +$301K 0.01% 765

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QS Batterymarch Financial Management's ANGO Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its AngioDynamics (ANGO) stake by 10% in Q3 2014, selling an estimated $277K and leaving 175,341 shares worth $2.41M. The position accounts for 0.06% of the portfolio, ranked #378.

QS Batterymarch Financial Management first reported a position in ANGO in Q4 2013 and has held it in 4 quarters since. The position peaked at $3.18M in Q2 2014. 105 funds tracked by Wall St. Rank hold ANGO as of Q3 2014.

  • QS Batterymarch Financial Management held 175,341 shares of AngioDynamics worth $2.41M as of Q3 2014.
  • QS Batterymarch Financial Management sold 19,410 AngioDynamics shares in Q3 2014, an estimated $277K.
  • AngioDynamics made up 0.06% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #378 holding.
  • QS Batterymarch Financial Management first reported a position in AngioDynamics in Q4 2013 and has held it in 4 quarters since.
  • QS Batterymarch Financial Management's AngioDynamics position peaked at $3.18M in Q2 2014.
  • 105 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.